European Journal of Biomedical and Pharmaceutical Sciences

PREVALENCE OF SUBCLINICAL HYPOTHYROIDISM IN PATIENTS WITH METABOLIC SYNDROME IN SOUTH INDIA

Silpa Choday*

ABSTRACT

Metabolic syndrome is a cluster of risk factors and is characterized by hypertension, atherogenic dyslipidemia, hyperglycemia, prothrombotic, and pro-inflammatory conditions.[1] The metabolic syndrome is also known as syndrome X, insulin resistance syndrome, and the deadly quartet. The metabolic syndrome is more common in genetically susceptible populations. Being overweight or obese, physical inactivity and an atherogenic diet commonly elicit clinical manifestations.[2] The risks of metabolic syndrome include cardiovascular disease and diabetes mellitus. In addition, Metabolic Syndrome (MetsS) is associated with several other comorbidities such as Non-Alcoholic Fatty Liver disease, sleep disorders, reproductive tract disorders, and microvascular disease.[3]

Keywords: .